BMY Stock - BRISTOL MYERS SQUIBB COFundamentals & Analysis

Pharmaceutical Preparations

Company Overview Bristol Myers Squibb is a global biopharmaceutical company developing and commercializing prescription medicines across oncology, immunology and cardiovascular disease, and its deterministic profile is currently middling across core financial dimensions (each major metric scores 5.0/10 and sits at the 50th percentile versus peers). Financial Stability and Peer Comparison Where the

BRISTOL MYERS SQUIBB CO

Pharmaceutical Preparations
Stock Price
$60.16
$-0.58 (-0.95%)
Jul 20, 2026
Debt to Equity
N/A
ROE
N/A
PE Ratio
N/A
EPS (Diluted)
N/A
No annual financial data available for analysis